245 related articles for article (PubMed ID: 7430557)
1. Serum thyroglobulin in thyroid carcinoma and other thyroid disorders.
Pacini F; Pinchera A; Giani C; Grasso L; Doveri F; Baschieri L
J Endocrinol Invest; 1980; 3(3):283-92. PubMed ID: 7430557
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.
Herle AJ; Uller RP
J Clin Invest; 1975 Aug; 56(2):272-7. PubMed ID: 1150869
[TBL] [Abstract][Full Text] [Related]
3. [A radioimmunoassay for the measurement of thyroglobulin in human serum and its application to clinical study (author's transl)].
Kishino B
Nihon Naibunpi Gakkai Zasshi; 1978 Jan; 54(1):43-53. PubMed ID: 631380
[TBL] [Abstract][Full Text] [Related]
4. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
[TBL] [Abstract][Full Text] [Related]
5. Thyroglobulin levels to follow-up patients with treated differentiated thyroid carcinoma.
Moser E; Braun S; Büell U; Kirsch CM; Tosch U; Wendt T
Cancer Detect Prev; 1984; 7(2):79-86. PubMed ID: 6424939
[TBL] [Abstract][Full Text] [Related]
6. [Serum thyroglobulin levels in patients with thyroid tumor].
Abe N; Ishida T; Sato K; Izuo M; Tarutani O
Nihon Naibunpi Gakkai Zasshi; 1986 Jan; 62(1):9-17. PubMed ID: 3699197
[TBL] [Abstract][Full Text] [Related]
7. [Human thyroglobulin radioimmunoassay--Preliminary results in serum and thyroid tissue (author's transl)].
Schlumberger M; Fragu P; Vignal A; Tubiana M
Ann Endocrinol (Paris); 1979; 40(4):439-40. PubMed ID: 583204
[TBL] [Abstract][Full Text] [Related]
8. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
9. Serum thyroglobulin concentrations and 131I whole body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy).
Pacini F; Pinchera A; Giani C; Grasso L; Baschieri L
Clin Endocrinol (Oxf); 1980 Jul; 13(1):107-10. PubMed ID: 7438460
[TBL] [Abstract][Full Text] [Related]
10. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.
Ozata M; Suzuki S; Miyamoto T; Liu RT; Fierro-Renoy F; DeGroot LJ
J Clin Endocrinol Metab; 1994 Jul; 79(1):98-105. PubMed ID: 8027262
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoassay for measurement of thyroglobulin in human serum.
Van Herle AJ; Uller RP; Matthews NI; Brown J
J Clin Invest; 1973 Jun; 52(6):1320-7. PubMed ID: 4739914
[TBL] [Abstract][Full Text] [Related]
12. Identification of thyroid hormone residues on serum thyroglobulin: a clue to the source of circulating thyroglobulin in thyroid diseases.
Druetta L; Bornet H; Sassolas G; Rousset B
Eur J Endocrinol; 1999 May; 140(5):457-67. PubMed ID: 10229914
[TBL] [Abstract][Full Text] [Related]
13. Serum thyroglobulin concentrations and (131)I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone.
David A; Blotta A; Bondanelli M; Rossi R; Roti E; Braverman LE; Busutti L; degli Uberti EC
J Nucl Med; 2001 Oct; 42(10):1470-5. PubMed ID: 11585859
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
Ng DC; Sundram FX; Sin AE
J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
16. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
[TBL] [Abstract][Full Text] [Related]
17. Serum thyroglobulin levels predict total body iodine scan findings in patients with treated well-differentiated thyroid carcinoma.
Charles MA; Dodson LE; Waldeck N; Hofeldt F; Ghaed N; Telepak R; Ownbey J; Burstein P
Am J Med; 1980 Sep; 69(3):401-7. PubMed ID: 7416187
[TBL] [Abstract][Full Text] [Related]
18. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
[TBL] [Abstract][Full Text] [Related]
19. High-sensitivity human thyroglobulin (hTG) immunoradiometric assay in the follow-up of patients with differentiated thyroid cancer.
Giovanella L; Ceriani L
Clin Chem Lab Med; 2002 May; 40(5):480-4. PubMed ID: 12113292
[TBL] [Abstract][Full Text] [Related]
20. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]